Wendel

LSE:0HZD Stock Report

Market Cap: €3.9b

Wendel Valuation

Is 0HZD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0HZD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0HZD (€93.22) is trading below our estimate of fair value (€116.94)

Significantly Below Fair Value: 0HZD is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0HZD?

Key metric: As 0HZD is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0HZD. This is calculated by dividing 0HZD's market cap by their current revenue.
What is 0HZD's PS Ratio?
PS Ratio0.5x
Sales€7.60b
Market Cap€3.93b

Price to Sales Ratio vs Peers

How does 0HZD's PS Ratio compare to its peers?

The above table shows the PS ratio for 0HZD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.5x
IGG IG Group Holdings
3.5x5.0%UK£3.3b
OSB OSB Group
1.8x-0.5%UK£1.4b
PAG Paragon Banking Group
3.1x3.2%UK£1.5b
PHLL Petershill Partners
5.6x-6.4%UK£2.6b
0HZD Wendel
0.5x4.5%€3.9b

Price-To-Sales vs Peers: 0HZD is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (3.5x).

Price to Sales Ratio vs Industry

How does 0HZD's PS Ratio compare vs other companies in the GB Diversified Financial Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
NBS Nationwide Building Society
0.3xn/aUS$1.52b
LEND Sancus Lending Group
0.3x15.1%US$3.61m
No more companies available in this PS range
0HZD 0.5xIndustry Avg. 2.0xNo. of Companies5PS01.22.43.64.86+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 0HZD is good value based on its Price-To-Sales Ratio (0.5x) compared to the UK Diversified Financial industry average (2x).

Price to Sales Ratio vs Fair Ratio

What is 0HZD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0HZD PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.5x
Fair PS Ratio2.1x

Price-To-Sales vs Fair Ratio: 0HZD is good value based on its Price-To-Sales Ratio (0.5x) compared to the estimated Fair Price-To-Sales Ratio (2.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0HZD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€93.22
€120.00
+28.7%
9.4%€130.00€100.00n/a6
Nov ’25€91.99
€118.50
+28.8%
8.9%€130.00€100.00n/a6
Oct ’25€91.71
€116.83
+27.4%
10.6%€130.00€100.00n/a6
Sep ’25€91.45
€116.83
+27.8%
10.6%€130.00€100.00n/a6
Aug ’25€88.90
€116.83
+31.4%
10.6%€130.00€100.00n/a6
Jul ’25€83.85
€115.67
+37.9%
10.0%€130.00€100.00n/a6
Jun ’25€90.75
€115.33
+27.1%
9.8%€130.00€100.00n/a6
May ’25€96.12
€115.33
+20.0%
9.8%€130.00€100.00n/a6
Apr ’25€94.60
€112.33
+18.8%
10.9%€130.00€95.00n/a6
Mar ’25€90.61
€110.43
+21.9%
11.1%€130.00€95.00n/a7
Feb ’25€84.32
€110.67
+31.2%
11.9%€130.00€95.00n/a6
Jan ’25€80.62
€110.67
+37.3%
11.9%€130.00€95.00n/a6
Dec ’24€78.26
€110.33
+41.0%
12.2%€130.00€95.00n/a6
Nov ’24€70.61
€110.33
+56.3%
12.2%€130.00€95.00€91.996
Oct ’24€75.05
€116.17
+54.8%
7.9%€130.00€100.00€91.716
Sep ’24€84.66
€116.17
+37.2%
7.9%€130.00€100.00€91.456
Aug ’24€89.74
€117.00
+30.4%
8.3%€130.00€100.00€88.906
Jul ’24€93.94
€126.10
+34.2%
11.8%€155.00€115.00€83.855
Jun ’24€100.25
€128.08
+27.8%
11.2%€155.00€115.00€90.756
May ’24€101.61
€128.08
+26.1%
11.2%€155.00€115.00€96.126
Apr ’24€97.69
€125.08
+28.0%
12.4%€155.00€110.00€94.606
Mar ’24€105.37
€123.17
+16.9%
12.7%€155.00€110.00€90.616
Feb ’24€97.08
€123.17
+26.9%
12.7%€155.00€110.00€84.326
Jan ’24€87.83
€121.83
+38.7%
12.7%€155.00€110.00€80.626
Dec ’23€89.60
€121.42
+35.5%
13.0%€155.00€107.50€78.266
Nov ’23€80.49
€121.42
+50.9%
13.0%€155.00€107.50€70.616

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

BFF Bank

€1.6b

Provides financial services to suppliers of the national health system and public administration sector in Italy, Croatia, the Czech Republic, France, Greece, Poland, Portugal, the Slovak Republic, and Spain.

0RON

€8.43

7D

-7.0%

1Y

-14.9%

HAL Trust

€10.3b

Operates through multi-sectors in Europe, the United States, Canada, Asia, and internationally.

0K9V

€114.20

7D

-0.3%

1Y

2.3%

Man Group

UK£2.4b

Man Group Limited is a publicly owned investment manager.

EMGL

UK£2.07

7D

3.9%

1Y

-5.9%